Vireo Growth (VREO) Q3 2025 earnings summary

Executive summary

• Q3 2025 GAAP revenue reached $91.7 million, up 264% year-over-year, driven by M&A and organic growth, with results aligned with management expectations.

• Integration of recent acquisitions is nearly complete, with realized corporate overhead synergies and full integration expected by year-end.

• First adult-use cannabis sales in Minnesota began in Q3, contributing to revenue growth and expected to drive future organic growth.

• Ended Q3 with over $117 million in cash, positioning for further acquisitions in a distressed industry.

• Announced acquisition of 86% of Schwazze's senior secured convertible notes, positioning to own the majority of Schwazze's assets and expand into Colorado and New Mexico.

Financial highlights

• Q3 GAAP revenue reached $91.7 million, up 264% year-over-year, driven by M&A and organic growth.

• Adjusted EBITDA for Q3 was $25.4 million, a 297% increase year-over-year, with margins above 25%.

• Adjusted Gross Profit for Q3 was $50.8 million, up 300% year-over-year; margin improved by 500 bps to 55.4%.

• Net loss for Q3 was $26.3 million, compared to a $4.9 million loss in the prior year period.

• Ended Q3 with $117.5 million in cash and total current assets of $191.1 million (excluding certain assets held for sale and income taxes receivable).

Outlook and guidance

• Expectation to achieve full integration of recent acquisitions by year-end and continue realizing synergies to improve gross and EBITDA margins.

• Management expects to remain acquisitive, leveraging a strong cash position in a distressed market.

• Refinancing of senior secured debt is expected to reduce annualized interest expense by $10 million.

• Anticipates Minnesota's adult-use market to be a significant revenue growth catalyst, with new production coming online in Q1 2026.

• Continued focus on optimizing operations and pursuing further M&A opportunities as 2025 ends.